Mankind Pharma Limited (NSEI: MANKIND)
Health Care · Pharmaceuticals · IN
Rs2,425.20
-1.25% today · -1.9% 1Y
Mankind Pharma Limited (NSEI: MANKIND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $10.47B and employs 20,451 people.
Over the last twelve months the share price has lost 1.9%, trading between 1.91K and 2.67K.
Tweenvest scores Mankind Pharma Limited across four factors: quality 66/100, value 69/100, growth 57/100, dividend 1/100. Its strongest factor is value.
MANKIND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.47B
- Revenue (TTM)
- $1.56B
- P/E
- 49.07
- EPS
- 49.42
- Dividend yield
- 0.08%
- Beta (5Y)
- 0.46
- 52-week high
- Rs2,674.00
- 52-week low
- Rs1,909.70
- Avg volume (3M)
- —
- Shares outstanding
- 413.00M
- Employees
- 20,451
- Next earnings
- —
About Mankind Pharma Limited
Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
- ISIN
- INE634S01028
- Founded
- 1991
- Listed since
- May 9, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.85 | -3.47% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.06 | -0.76% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.94 | -1.60% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.25 | -1.14% |
Figures last refreshed Aug 18, 2026.